Evaluation Of Renal Masses Using Magnetic Resonance
Funder
National Health and Medical Research Council
Funding Amount
$657,897.00
Summary
This project will investigate use of an imaging instrument to identify renal cancers that are potentially harmless from aggressive renal cancers. Currently, such differentiation requires biopsies, and the outcome is often unnecessary surgical removal of whole or part of the diseased kidney. Long term, this project will provide knowledge to determine aggressiveness of a renal cancer non-invasively, without having to perform an operation. The approach was previously successful for breast cancer.
Understanding How Toxins Interact With Lipid Membranes And Ion Channels
Funder
National Health and Medical Research Council
Funding Amount
$598,220.00
Summary
Chronic pain affects one in five Australians and current treatments have limited effectiveness, with only about one third of patients getting meaningful, pain relief. The aim of the current project is to create alternative treatments for pain that can potentially lead to the reduced suffering and improvement of life quality of many Australians. To achieve this aim we propose to study how spider toxins interact with cells and deactivate sensor targets responsible for chronic pain.
Understanding How Perforin Forms Pores: The Role Of Calcium And Lipids.
Funder
National Health and Medical Research Council
Funding Amount
$797,813.00
Summary
This grant aims to study perforin, a key part of the mammalian immune system. The work will facilitate the development of perforin inhibitors. It is anticipated that these data will be of utility in developing first in class drugs to improve the success of bone marrow transplantation.
Burkholderia Pseudomallei Disulfide-forming Proteins: Structure, Function And Inhibition
Funder
National Health and Medical Research Council
Funding Amount
$707,032.00
Summary
Our research will lead to a better understanding of melioidosis, a disease endemic to Northern Australia and which impacts indigenous communities at twice the rate of the rest of the population. This project will also aim to generate new compounds with the potential for development as treatments against this devastating disease.
A Selective Prevention Trial Using Novel Pharmacotherapies In An Older Age Cohort At Risk For Depression
Funder
National Health and Medical Research Council
Funding Amount
$975,259.00
Summary
The study will examine whether omega-3 fatty acids or antidepressants prevent the onset of depression in a group of older community participants who have previously been identified as being "at risk" of depression. The study will incorporate sophisticated brain scanning methods, as well as tests of brain functioning to determine acute brain changes, reduction in cognitive decline and prevention of depression over a one-year period.
Enhancing The Immune Response To Disordered Malaria Antigens
Funder
National Health and Medical Research Council
Funding Amount
$643,739.00
Summary
Half of the worlds population live at risk of malaria, and the disease kills half a million people a year, predominantly young children. Despite recent progress, a vaccine with the efficacy required to help control and ultimately eradicate malaria remains out of reach. This project studies an important class of proteins likely to form part of a future malaria vaccine, and will develop new ways to improve their effectiveness as vaccine components.
Role Of Neurogenesis In Clinical Recovery From Depression During ECT: Application Of A Novel In Vivo Magnetic Resonance Spectroscopy Technology
Funder
National Health and Medical Research Council
Funding Amount
$587,478.00
Summary
Neurogenesis refers to the generation of new brain cells, which is now known to continue well into adulthood. On the basis of animal studies, deficiencies in neurogenesis have been implicated in development of depression, and stimulation of neurogenesis proposed as one of the ways that anti-depressants may work. Using the latest technological advances in brain imaging, we will for the first time assess the merit of these theories in humans with depression before and after treatment.
Defining The Molecular Mechanisms Of Lyssavirus Replication And Immune Evasion: The P Protein Axis
Funder
National Health and Medical Research Council
Funding Amount
$900,995.00
Summary
Lyssaviruses such as rabies virus (RABV) and Australian bat lyssavirus cause rabies disease, which has the highest case-fatality rate of known infectious diseases, causing >60,000 human deaths/year. Critical to this is a protein produced by the virus that is important for both viral growth and evasion of the host's immune defences. This project aims to understand the molecular mechanisms underlying these processes, which may lead to new approaches to combat currently incurable viral diseases.
Control Of Immunoreceptor Assembly And Function By Intramembrane Sequence Elements
Funder
National Health and Medical Research Council
Funding Amount
$403,121.00
Summary
The cells of the immune system constantly survey their environment for changes that indicate damage. To sense their surroundings cells employ a host of receptors that are associated with signalling adapter proteins that initiate signalling cascades inside the cell when receptors bind ligands. This project seeks to determine the structural mechanisms of signal propagation across the plasma membrane of immune cells.
STABILISING G PROTEIN-COUPLED RECEPTORS FOR DRUG DISCOVERY
Funder
National Health and Medical Research Council
Funding Amount
$628,140.00
Summary
Prescription drugs targeting human proteins called GPCRs are sold as effective treatments for many diseases. However, there are over 800 different types of GPCRs in the human body and only a small fraction is targeted by drugs, mainly because GPCRs are unstable and thus difficult to work with in the laboratory. We are applying newly developed technologies to engineer stabilised ?1-adrenoceptors, a class of GPCRs, for drug discovery against cardiovascular diseases, epilepsy and neurodegeneration